At 3-0 to the Brilos, the boardroom pay game has changed forever | Nils Pratley

As Smith & Nephew is ‘British in listing only’ investors have been persuaded the CEO should be remunerated accordinglyNearly half of Smith & Nephew investors revolt against CEO pay riseOur performance has been so bad that we must pay our executives more. If this corporate pitch for an increase in top-level rewards strikes you as laughably unconvincing, you’d be surprised.At Smith & Nephew, the FTSE 100 medical devices group whose shares were touching £20 in 20